Arch Biopartners, Inc. (ARCH.V)
0.87
0.00 (0.00%)
CAD |
TSXV |
Oct 23, 16:00
Arch Biopartners Debt to Equity Ratio : -0.6842 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6842 |
| March 31, 2026 | -0.7494 |
| December 31, 2025 | -0.7316 |
| September 30, 2025 | -0.7317 |
| June 30, 2025 | -0.7298 |
| March 31, 2025 | -0.7605 |
| December 31, 2024 | -0.7697 |
| September 30, 2024 | -0.6371 |
| June 30, 2024 | -0.812 |
| March 31, 2024 | -0.7971 |
| December 31, 2023 | -0.8816 |
| September 30, 2023 | -0.9104 |
| June 30, 2023 | -0.8651 |
| March 31, 2023 | -1.090 |
| December 31, 2022 | -0.9826 |
| September 30, 2022 | -0.9871 |
| June 30, 2022 | -1.104 |
| March 31, 2022 | -1.116 |
| December 31, 2021 | -1.084 |
| September 30, 2021 | -1.330 |
| June 30, 2021 | -1.170 |
| March 31, 2021 | -0.5932 |
| December 31, 2020 | -0.7077 |
| September 30, 2020 | -0.8765 |
| June 30, 2020 | -1.303 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.9993 |
| December 31, 2019 | -0.8283 |
| September 30, 2019 | -0.9943 |
| June 30, 2019 | -1.296 |
| March 31, 2019 | -0.8545 |
| December 31, 2018 | -0.7891 |
| September 30, 2018 | -1.418 |
| June 30, 2018 | -5.332 |
| March 31, 2018 | -5.711 |
| December 31, 2017 | -0.9386 |
| September 30, 2017 | -0.6202 |
| June 30, 2017 | -0.6063 |
| March 31, 2017 | -1.338 |
| December 31, 2016 | -0.6789 |
| September 30, 2016 | -1.285 |
| June 30, 2016 | -7.142 |
| March 31, 2016 | -1.770 |
| December 31, 2015 | 85.44 |
| September 30, 2015 | 2.320 |
| June 30, 2015 | 0.9821 |
| March 31, 2015 | 0.6492 |
| December 31, 2014 | -2.047 |
| September 30, 2014 | -53.14 |
| June 30, 2014 | -1.291 |
| March 31, 2014 | -2.519 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Innovotech, Inc. | 0.0642 |
| Kane Biotech, Inc. | -1.975 |
| Quest PharmaTech, Inc. | 0.0378 |
| BriaCell Therapeutics Corp. | 0.00 |
| Vaxil Bio Ltd. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0572M |
| Total Liabilities (Quarterly) | 4.043M |
| Shareholders Equity (Quarterly) | -3.986M |
| Current Ratio | 0.0141 |
| Net Debt Paydown Yield | 0.05% |